Tradestie Institutional Equity Comparison Engine

DARE vs GNPX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

GNPX Overall Edge

GNPX Captures Institutional Edge (2โ€“1 Pillars ยท 4โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Genprex, Inc. Common Stock (GNPX) driven by superior Growth & Margin, Momentum & Technical while DARE counters with relative strength in Valuation. Fundamentally, DARE trades at 1.3x Forward P/E with -746.1% operating margin (+2005.6% YoY revenue) versus GNPX at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, DARE sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against GNPX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner DARE
DARE 1.3x vs GNPX N/M Fwd P/E
Growth & Margin Winner GNPX
Op Margin -746.1% vs 0.0% ยท YoY +2005.6% vs +0.0%
Momentum & Technical Winner GNPX
1Y -76.2% vs -56.6% ยท 52W Pos 0% vs 11%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
DARE NASDAQ
Dare Bioscience, Inc. Common Stock
Pharmaceutical Preparations
$0.41
-9.86% 1D
Market Cap $9.6M
1M Return -37.48%
1Y Return -76.17%
Forward P/E 1.3x
Unified AI Score
45.4 / 100 HOLD
Tech 40.0 Fund 46.0 Flow 50.0 Mom 55.0
GNPX NASDAQ
Genprex, Inc. Common Stock
Pharmaceutical Preparations
$1.45
-13.17% 1D
Market Cap $2.2M
1M Return -26.77%
1Y Return -56.59%
Forward P/E N/M
Unified AI Score
42.2 / 100 HOLD
Tech 25.0 Fund 47.0 Flow 50.0 Mom 59.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: DARE -76.17% GNPX -56.59% Spread: +19.59 pp (GNPX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
DARE TTM Op. Margin: -746.1% GNPX TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DARE vs GNPX. Trailing 12-month operating profitability (DARE -746.1% vs GNPX 0.0%) and valuation multiples (DARE 1.3x vs GNPX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: DARE (4) vs GNPX (4)
Institutional Metric DARE GNPX Criterion Row Winner
Market Capitalization Scale $9.6M $2.2M Larger Scale Tie
Trailing P/E Ratio Valuation 1.3x N/M Lower Multiple DARE
Forward P/E Ratio Valuation 1.3x N/M Lower Multiple DARE
Revenue Growth (YoY) Growth +2005.6% +0.0% Higher Growth DARE
Operating Margin (TTM) Profitability -746.1% 0.0% Higher Margin GNPX
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -407.1% -233.7% Higher ROE GNPX
52-Week Range Position Momentum 0% ($0โ€“$4) 11% ($0โ€“$10) Stronger Trend GNPX
Beta / 30D Volatility Risk Regime 1.59ฮฒ ยท 112% Vol -4.68ฮฒ ยท 96% Vol Lower Realized Risk GNPX
Unified Institutional Score Composite Signal 45.4 / 100 (HOLD) 42.2 / 100 (HOLD) Higher Composite DARE

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full DARE vs GNPX Buy Guide
DARE UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live DARE Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
GNPX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live GNPX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither DARE nor GNPX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.